loadpatents
Patent applications and USPTO patent grants for Vamsi Krishna; Bandi.The latest application filed is for "process for preparation of ((3r,11br)-1,3,4,6,7,11b-hexahydro-9,10-di(methoxy-d3)-3-(2-methylpropyl)- -2h-benzo[a]quinolizin-2-one".
Patent | Date |
---|---|
Process for the preparation of diphenylpyrazine derivatives Grant 11,434,206 - Parthasaradhi Reddy , et al. September 6, 2 | 2022-09-06 |
Process For Preparation Of ((3r,11br)-1,3,4,6,7,11b-hexahydro-9,10-di(methoxy-d3)-3-(2-methylpropyl)- -2h-benzo[a]quinolizin-2-one App 20210230155 - PARTHASARADHI REDDY; Bandi ;   et al. | 2021-07-29 |
Process for the preparation of lomitapide Grant 10,934,251 - Parthasaradhi Reddy , et al. March 2, 2 | 2021-03-02 |
Process For The Preparation Of Diphenylpyrazine Derivatives App 20200361876 - Parthasaradhi Reddy; Bandi ;   et al. | 2020-11-19 |
Process for the preparation of a dual-acting angiotensin receptor-neprilysin inhibitor compound Grant 10,822,314 - Parthasaradhi Reddy , et al. November 3, 2 | 2020-11-03 |
Process for the preparation of diphenylpyrazine derivatives Grant 10,815,204 - Parthasaradhi Reddy , et al. October 27, 2 | 2020-10-27 |
Process For The Preparation of Lomitapide App 20200190018 - Parthasaradhi Reddy; Bandi ;   et al. | 2020-06-18 |
Process for the preparation of a dual-acting angiotensin receptor-neprilysin inhibitor compound Grant 10,562,867 - Parthasaradhi Reddy , et al. Feb | 2020-02-18 |
Process For The Preparation Of A Dual-acting Angiotensin Receptor-neprilysin Inhibitor Compound App 20200048210 - PARTHASARADHI REDDY; Bandi ;   et al. | 2020-02-13 |
Process for the preparation of Quinolin-2(1H)-one derivatives Grant 10,464,931 - Parthasaradhi Reddy , et al. No | 2019-11-05 |
Crystalline form of Eltrombopag free acid Grant 10,336,706 - Parthasaradhi Reddy , et al. | 2019-07-02 |
Polymorphs and process for the preparation of quinazolinyl derivatives Grant 10,329,281 - Parthasaradhi Reddy , et al. | 2019-06-25 |
Process For The Preparation Of Diphenylpyrazine Derivatives App 20190112277 - Parthasaradhi Reddy; Bandi ;   et al. | 2019-04-18 |
Process For The Preparation Of A Dual-acting Angiotensin Receptor-neprilysin Inhibitor Compound App 20190112278 - PARTHASARADHI REDDY; Bandi ;   et al. | 2019-04-18 |
Process for the preparation of a dual-acting angiotensin receptor-neprilysin inhibitor compound Grant 10,214,497 - Parthasaradhi Reddy , et al. Feb | 2019-02-26 |
Rufinamide solid dispersion Grant 10,206,874 - Parthasaradhi Reddy , et al. Feb | 2019-02-19 |
Process For The Preparation Of Quinolin-2(ih)-one Derivatives App 20190010145 - Parthasaradhi Reddy; Bandi ;   et al. | 2019-01-10 |
Process For The Preparation Of A Dual-acting Angiotensin Receptor-neprilysin Inhibitor Compound App 20180244636 - PARTHASARADHI REDDY; Bandi ;   et al. | 2018-08-30 |
Process for the preparation of lomitapide Grant 10,023,526 - Parthasaradhi Reddy , et al. July 17, 2 | 2018-07-17 |
Polymorphs and Process for the Preparation of Quinazolinyl Derivatives App 20180194754 - PARTHASARADHI REDDY; Bandi ;   et al. | 2018-07-12 |
Process For The Preparation Of Lomitapide App 20180105487 - PARTHASARADHI REDDY; BANDI ;   et al. | 2018-04-19 |
Process for pralatrexate Grant 9,783,542 - Parthasaradhi Reddy , et al. October 10, 2 | 2017-10-10 |
Crystalline Form Of Eltrombopag Free Acid App 20170275255 - PARTHASARADHI REDDY; BANDI ;   et al. | 2017-09-28 |
Polymorphs of lomitapide and its salts Grant 9,624,172 - Parthasaradhi Reddy , et al. April 18, 2 | 2017-04-18 |
Amorphous darunavir Grant 9,624,236 - Parthasaradhi Reddy , et al. April 18, 2 | 2017-04-18 |
Polymorphs of azilsartan medoxomil Grant 9,624,207 - Parthasaradhi Reddy , et al. April 18, 2 | 2017-04-18 |
Polymorphs of Lomitapide and its Salts App 20170057917 - Parthasaradhi Reddy; Bandi ;   et al. | 2017-03-02 |
Process for Regorafenib Grant 9,518,020 - Parthasaradhi Reddy , et al. December 13, 2 | 2016-12-13 |
Process For Regorafenib App 20160251313 - PARTHASARADHI REDDY; Bandi ;   et al. | 2016-09-01 |
Linagliptin solid dispersion Grant 9,381,199 - Parthasaradhi Reddy , et al. July 5, 2 | 2016-07-05 |
Crystalline hydrochloride salt of darunavir Grant 9,175,005 - Parthasaradhi Reddy , et al. November 3, 2 | 2015-11-03 |
Linagliptin Solid Dispersion App 20150290199 - Parthasaradhi Reddy; Bandi ;   et al. | 2015-10-15 |
Novel Polymorphs Of Azilsartan App 20150291574 - Parthasaradhi Reddy; Bandi ;   et al. | 2015-10-15 |
Process for sorafenib tosylate polymorph III Grant 9,156,789 - Parthasaradhi Reddy , et al. October 13, 2 | 2015-10-13 |
Process for rilpivirine using novel intermediate Grant 9,139,535 - Parthasaradhi Reddy , et al. September 22, 2 | 2015-09-22 |
Process For Pralatrexate App 20150252045 - Parthasaradhi Reddy; Bandi ;   et al. | 2015-09-10 |
Process for the resolution of omeprazole Grant 9,115,118 - Parthasaradhi Reddy , et al. August 25, 2 | 2015-08-25 |
Novel Polymorphs Of Azilsartan Medoxomil App 20150183767 - Parthasaradhi Reddy; Bandi ;   et al. | 2015-07-02 |
Rufinamide Solid Dispersion App 20150182458 - Parthasaradhi Reddy; Bandi ;   et al. | 2015-07-02 |
Process For Rilpivirine Using Novel Intermediate App 20150183751 - Parthasaradhi Reddy; Bandi ;   et al. | 2015-07-02 |
Elvitegravir Solid Dispersion App 20150141457 - Parthasaradhi Reddy; Bandi ;   et al. | 2015-05-21 |
Process For Sorafenib Tosylate Polymorph Iii App 20150133670 - Parthasaradhi Reddy; Bandi ;   et al. | 2015-05-14 |
Crystalline Hydrochloride Salt Of Darunavir App 20150080589 - PARTHASARADHI REDDY; Bandi ;   et al. | 2015-03-19 |
Amorphous Form Of Lopinavir And Ritonavir Mixture App 20150080420 - Parthasaradhi Reddy; Bandi ;   et al. | 2015-03-19 |
Process for cinacalcet hydrochloride Grant 8,921,606 - Parthasaradhi Reddy , et al. December 30, 2 | 2014-12-30 |
Polymorphs of pitavastatin calcium Grant 8,912,333 - Parthasaradhi Reddy , et al. December 16, 2 | 2014-12-16 |
Process for the resolution of omeprazole Grant 8,748,619 - Parthasaradhi Reddy , et al. June 10, 2 | 2014-06-10 |
Process For Febuxostat App 20140112992 - Parthasaradhi Reddy; Bandi ;   et al. | 2014-04-24 |
Amorphous Form Of Lopinavir And Ritonavir Mixture App 20140066468 - Parthasaradhi Reddy; Bandi ;   et al. | 2014-03-06 |
Process for etravirine intermediate and polymorphs of etravirine Grant 8,598,341 - Parthasaradhi Reddy , et al. December 3, 2 | 2013-12-03 |
Novel Polymorphs Of Pitavastatin Calcium App 20130237563 - Parthasaradhi Reddy; Bandi ;   et al. | 2013-09-12 |
Novel Polymorphs Of Febuxostat App 20130190368 - Parthasaradhi Reddy; Bandi ;   et al. | 2013-07-25 |
Process For Olmesartan Medoxomil App 20130190506 - Parthasaradhi Reddy; Bandi ;   et al. | 2013-07-25 |
Process For Cinacalcet Hydrochloride App 20130178654 - Parthasaradhi Reddy; Bandi ;   et al. | 2013-07-11 |
Salts Of Raltegravir App 20130137868 - Parthasaradhi Reddy; Bandi ;   et al. | 2013-05-30 |
Process For Etravirine Intermediate And Polymorphs Of Etravirine App 20130096148 - Parthasaradhi Reddy; Bandi ;   et al. | 2013-04-18 |
Optical resolution of substituted 2-(2-pyridinylmethylsulphinyl)-1H-benzimidazoles Grant 8,420,822 - Parthasaradhi Reddy , et al. April 16, 2 | 2013-04-16 |
Crystalline Hydrochloride Salt Of Darunavir App 20130072552 - Parthasaradhi Reddy; Bandi ;   et al. | 2013-03-21 |
Process For The Resolution Of Omeprazole App 20120215003 - Parthasaradhi Reddy; Bandi ;   et al. | 2012-08-23 |
Optical Resolution Of Substituted 2-(2-pyridinylmethylsulphinyl)-1h-benzimidazoles App 20120197021 - Parthasaradhi Reddy; Bandi ;   et al. | 2012-08-02 |
Polymorphs Of Darunavir App 20110313035 - Parthasaradhi Reddy; Bandi ;   et al. | 2011-12-22 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.